Ibrutinib is a BTK inhibitor, which is used to treat MCL, CLL, and Waldenström’s Macroglobulinemia. It works by blocking BTK, an enzyme important for cancer cell growth and survival. You can get it as a capsule or tablet, each 140 mg strong.
The usual dose is 420 to 560 mg, taken just once each day. The medication comes in bottles that hold 90 tablets. The drug messes with the BTK signaling path, which is super important for cancer cells to grow.
Common side effects might be bruising, spots that look like bruises, nosebleeds, bleeding gums, blood in pee or poop, feeling weak, coughing, a sore throat, fever, shivers, or other signs of infection. Always talk to a healthcare pro for more details on how to use it right, what dose to take, and what side effects to watch out for.
